PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1493854
PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1493854
The global flow cytometry market is estimated to reach USD 10.3 Billion by 2032 from USD 5.1 billion in 2024, at a CAGR of 9.2% during the forecast period of 2024 to 2032. Advancements in reagent technologies, such as fluorophore conjugation and specificity enhancement is one of the major factor uplifting the market growth. The dominance of the reagents and consumables segment among product and services factors is notable in the flow cytometry market. This segment holds sway due to continuous demand for antibodies, dyes, and other consumables essential for cell analysis. As the use of flow cytometry expands in research, clinical diagnostics, and drug development, the need for high-quality reagents remains constant.
Scope of the Report | |
---|---|
Years Considered for the Study | 2022-2032 |
Base Year | 2023 |
Forecast Period | 2024-2032 |
Units Considered | Value (USD) Bn and Volume (Units) |
Segments | By Technology, Product & Service, Application & End User |
Regions covered | North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa |
"Cell-Based flow cytometry market is likely to grow at faster pace"
Based on the technology, the flow cytometry market is cell-based and bead-based flow cytomtery. Cell-based flow cytometry segment dominated the market in 2023. The dominance of cell-based flow cytometry in the technology segment is pronounced due to its versatility in analyzing various cell types and biomarkers. Its ability to provide quantitative and qualitative data swiftly has made it indispensable in biomedical research, clinical diagnostics, and drug discovery, thus driving its market significance.
"The research application dominated the applications segments"
Based on the end user, the flow cytometry market is segmented into research applications, clinical applications, and industrial applications. The research application dominanted the segment however clinical application is anticipated to grow at significant CAGR during the forecast period. The extensive use of flow cytometry in basic and translational research across diverse fields such as immunology, oncology, and microbiology is likely to drive the segmental growth.
"Asia Pacific region estimated to show fastest growth rate."
Geographically, the flow cytometry market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East and Africa. In 2023, North America accounted for the major share of the flow cytometry market. The Asia Pacific region is likely to grow at significant CAGR during the forecast period owing to various factors such as as increasing investment in healthcare infrastructure, rising R&D activities in life sciences, and growing awareness about personalized medicine are driving this growth. Moreover, countries like China, Japan, India, and South Korea are witnessing substantial adoption of flow cytometry technologies in research, clinical diagnostics, and drug discovery.
This report provides a detailed picture of the flow cytometry market. It aims at estimating the size and future growth potential of the market across different segments such as technology, product & services, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles, recent developments, and key market strategies.
The report will help market leaders/new entrants by providing them with the estimations of the revenue numbers for the overall market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.